VECTUS BIOSYSTEMS LIMITED — Director's Dealing 2019

Dec 23, 2019

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Vectus Biosystems Limited (ASX:VBS) ABN 54 117 526 137

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Ronald Cecil Shnier
Date of last notice	26 February 2016 (Appendix 3X)

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Panleaf Pty Ltd (Ronald Cecil Shnier is the sole shareholder of the trustee, Panleaf Pty Ltd, and he is a beneficiary of The Shnier Family Trust.)
Date of change	20 December 2019
No. of securities held prior to change	100,000 fully paid ordinary shares
Class	Convertible Notes
Number acquired	200,000
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Issue price of $0.50

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	100,000 fully paid ordinary shares 200,000 Convertible Notes, with a 6% interest rate per annum over 36 months, capitalised and paid on the maturity date, being 27 September 2022.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of Convertible Notes (following shareholder approval at the 22 November 2019 Annual General Meeting) at $0.50 each for a total of $100,000, with 36 months until maturity date, plus 6% interest rate per annum capitalised and paid on maturity date, being 27 September 2022.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	None
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 – +Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade toproceed during thisperiod?
If prior written clearance was provided, on what date was thisprovided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011